May 16th 2024
Research indicates serum LOXL2 levels could serve as a predictor for hepatocellular carcinoma (HCC) risk in HCV patients who have achieved sustained virological response (SVR).
The Impact on Non-Alcohol Fatty Liver Disease With Previous Hepatitis Infections
October 3rd 2023A study highlights that viral infections can accelerate the progression of NAFLD to more severe conditions like non-alcoholic steatohepatitis (NASH) and fibrosis, emphasizing the importance of recognizing these complex relationships.
Read More
CDC Publishes 2 Reports on Hepatitis Incidence Rates and Progress Towards 2025 Goals
September 10th 2023The federal agency’s reports shows decreases in both hepatitis A and B, but hepatitis C saw a significant increase during 2021. However, the investigators note the pandemic may have impacted statistics and progress towards goals.
Read More
WHO Updates Recommendations for HIV, Hepatitis, STI Interventions in Prisons
July 26th 2023The update refreshes the organization's 2022 guidance on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations, focusing on people in prisons and other closed settings.
Read More